Benzinga | Aug 13, 2020 09:05AM EDT

Microbot Medical To Share Current Results Of A Feasibility Animal Study Utilizing The LIBERTY Robotic System On Aug. 17

HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (NASDAQ:MBOT), will provide initial results of a feasibility animal study performed using the Company's LIBERTY Robotic System.



Harel Gadot, CEO, President and Chairman along with other members of the management team are scheduled to conduct one-on-one meetings during the day. The investor presentation, which will highlight the initial results of the feasibility animal study, will be made available prior to the first meeting and accessed via the 'Investors' section, under 'Presentation + Resources' of the Company's website at www.microbotmedical.com.

The Company's LIBERTY robotic system, which was unveiled in January 2020, is the world's first fully disposable robotic system which features a unique compact design; with the capability to be operated remotely, it is being designed to reduce radiation exposure as well as the physical strain to the physician. Incorporating the technology the Company acquired from CardioSert into the LIBERTY Robotic System, it has the potential to eliminate the use of multiple consumables through its "One & Done" capabilities.